Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹1,669 Cr₹1,541 Cr₹1,242 Cr₹1,107 Cr₹968 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,669 Cr based on Mar2023 Consolidated results.
Year Revenue
Mar2023₹1,669 Cr
Mar2022₹1,541 Cr
Mar2021₹1,242 Cr
Mar2020₹1,107 Cr
Mar2019₹968 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2023 ₹1,669 Cr
8.30
Mar2022 ₹1,541 Cr
24.10
Mar2021 ₹1,242 Cr
12.19
Mar2020 ₹1,107 Cr
14.26
Mar2019 ₹968 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,110.8 Cr 2.7% -0.6% 2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

2.7%

-0.6%

2.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses